Clinical Trial Update: Sitagliptin in Combination With Metformin and Sulfonylurea [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluates sitagliptin in combination with metformin and a sulfonylurea for type 2 diabetes mellitus; the study has completed and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)
• Sulfonylurea (unspecified)
• metformin (metformin)

Snippet

Sponsor: Charles Drew University of Medicine and Science | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2014-11-26